P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL). (23rd June 2022) - Zhu, H.; Sha, Y.; Miao, Y.; Qin, S.; Wu, W.; Qiu, J.; Mi, H.; Yang, Y.; Peng, C.; Ding, C.; Wang, Z.; Fan, L.; et al.